NCT02947386 2023-10-05Nimotuzumab and Nivolumab in Treating Patients With Advanced Non-small Cell Lung CancerRoswell Park Cancer InstitutePhase 1 Completed7 enrolled
NCT02577341 2021-02-11Nimotuzumab Combined With Chemoradiotherapy for Unresectable Locally Advanced Squamous Cell Lung CancerSun Yat-sen UniversityPhase 2 Completed122 enrolled